DE2219408A1 - Substituierte Benzimidazolderivate - Google Patents

Substituierte Benzimidazolderivate

Info

Publication number
DE2219408A1
DE2219408A1 DE19722219408 DE2219408A DE2219408A1 DE 2219408 A1 DE2219408 A1 DE 2219408A1 DE 19722219408 DE19722219408 DE 19722219408 DE 2219408 A DE2219408 A DE 2219408A DE 2219408 A1 DE2219408 A1 DE 2219408A1
Authority
DE
Germany
Prior art keywords
methoxy
hydrogen
lower alkoxy
benzimidazolyl
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19722219408
Other languages
German (de)
English (en)
Inventor
Tsung-Ying Westfield; Grenda Victor Joseph Warren; Czaja Robert Francis Scotch Plains; N.J. Shen (V.StA.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2219408A1 publication Critical patent/DE2219408A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19722219408 1971-04-21 1972-04-20 Substituierte Benzimidazolderivate Pending DE2219408A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13618671A 1971-04-21 1971-04-21
US13818671A 1971-04-21 1971-04-21

Publications (1)

Publication Number Publication Date
DE2219408A1 true DE2219408A1 (de) 1972-10-26

Family

ID=26834087

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19722219408 Pending DE2219408A1 (de) 1971-04-21 1972-04-20 Substituierte Benzimidazolderivate

Country Status (4)

Country Link
DE (1) DE2219408A1 (lt)
FR (1) FR2133979B1 (lt)
GB (1) GB1356763A (lt)
NL (1) NL7204972A (lt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
ES2605792T3 (es) 2004-05-13 2017-03-16 Icos Corporation Quinazolinona usada como inhibidor de la fosfatidilinositol 3-quinasa delta humana
WO2010057048A1 (en) 2008-11-13 2010-05-20 Calistoga Pharmaceuticals Inc. Therapies for hematologic malignancies
US9492449B2 (en) 2008-11-13 2016-11-15 Gilead Calistoga Llc Therapies for hematologic malignancies
CN102439012A (zh) 2009-03-24 2012-05-02 吉里德卡利斯托加公司 2-嘌呤基-3-甲苯基-喹唑啉酮衍生物的阻转异构体和使用方法
KR20120005523A (ko) 2009-04-20 2012-01-16 길리아드 칼리스토가 엘엘씨 고형 종양의 치료 방법
AU2010276160A1 (en) 2009-07-21 2012-02-09 Gilead Calistoga Llc Treatment of liver disorders with PI3K inhibitors
NZ603789A (en) * 2010-05-26 2015-03-27 Sunovion Pharmaceuticals Inc Heteroaryl compounds and methods of use thereof
EP3210984B1 (en) 2011-01-11 2019-06-19 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
ES2848273T3 (es) 2012-03-05 2021-08-06 Gilead Calistoga Llc Formas polimórficas de (S)-2-(1-(9H-purin-6-ilamino)propilo)-5-fluoro-3-fenilquinazolina-4(3H)-ona
SG11201604825VA (en) 2013-12-20 2016-07-28 Gilead Calistoga Llc Process methods for phosphatidylinositol 3-kinase inhibitors
AU2014364414A1 (en) 2013-12-20 2016-06-30 Gilead Calistoga Llc Polymorphic forms of a hydrochloride salt of (S) -2-(1-(9H-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3H) -one
KR20170012560A (ko) 2014-06-13 2017-02-02 길리애드 사이언시즈, 인코포레이티드 포스파티딜이노시톨 3-키나제 억제제
CN111944340B (zh) * 2020-08-21 2022-08-05 无锡市乐卡新材料有限公司 一种耐盐雾防锈涂料

Also Published As

Publication number Publication date
FR2133979A1 (lt) 1972-12-01
GB1356763A (en) 1974-06-12
FR2133979B1 (lt) 1975-10-31
NL7204972A (lt) 1972-10-24

Similar Documents

Publication Publication Date Title
DE2058295C3 (de) Xanthen-9-on-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2219408A1 (de) Substituierte Benzimidazolderivate
DE1695556B2 (de) 3Alkyl-l,2,3,4,4a,9-hexahydropyrazino [1,2-f] morphanthridinderivate
DE1235321B (de) Verfahren zur Herstellung von substituierten Benzimidazolen und ihren Salzen
DD224593A5 (de) Verfahren zur herstellung von 1-heteroaryl-4-[-2,5-pyrrolidindion-1-yl]alkyl]piperazinderivaten
US4188486A (en) 2-Substituted benzimidazole compounds
DE2557342A1 (de) Basisch substituierte indolderivate und verfahren zu ihrer herstellung
DE1620450A1 (de) Substituierte Benzimidazole
DE2848263A1 (de) Chinazolinderivate, verfahren zu deren herstellung und antihypertensive arzneimittel, welche diese enthalten
DE3042481A1 (de) (omega)-(2-oxo-benzazolinyl)-alkansaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3532279A1 (de) 1,4-benzoxathiin-derivate
CH617701A5 (lt)
CH511838A (de) Verfahren zur Herstellung von neuen Indolderivaten
EP0072961B1 (de) 1-Phenylindazol-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2550959C3 (de) Tetrazolyl-imidazole und Tetrazolyl--benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2609437C2 (lt)
CH651027A5 (de) Heterocyclische verbindungen, ihre herstellung und verwendung.
DD153368A5 (de) Verfahren zur herstellung von tetrahydrochinolinderivaten
CH634320A5 (en) Naphthyridines
DE2042758A1 (de) Verfahren zur Herstellung von Benzodiazepinderivaten
CH634828A5 (de) Verfahren zur herstellung neuer oximaetherverbindungen.
CH461489A (de) Verfahren zur Herstellung von neuen Oxazolderivaten
DE1620368A1 (de) Verfahren zur Herstellung neuer heterocyclischer Verbindungen
DE1695849A1 (de) Verfahren zur Herstellung neuer Pyrimidinderivate
DE1914005C (de) 1-Phenylbenzimidazole